Article
Modified Guishen Pill Ameliorates Polycystic Ovary Syndrome in Rats Through Anti-inflammation and Modulating Gut Microbiota
2021-10-12
Abstract excerpt
<h4>Background: </h4> Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder often accompanied by chronic low-grade inflammation. Western medicine often causes negative side effects, such as premature ovarian failure. Therefore, this study evaluates the efficacy of modified Guishen pill (MGP) in ameliorating letrozole-induced PCOS in rats. Methods Six-week-old specific-pathogen free (SPF)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- abc278c4-4535-59ca-a6ed-7743ba7ecd6d
- DOI
- 10.21203/rs.3.rs-958986/v1
